Skip to main content
OpenTrials

Clinical trial condition

LAL-Deficiency

Explore clinical trials studying LAL-Deficiency. Study availability and eligibility vary by location and protocol.

2 public trials 0 recruiting studies
Refine in advanced search Browse all conditions

LAL-Deficiency trial results

Completed

Safety, Tolerability and Pharmacokinetics of SBC-102 (Sebelipase Alfa) in Adult Participants With Lysosomal Acid Lipase Deficiency

NCT01307098

Conditions
Cholesterol Ester Storage Disease, Cholesterol Ester Storage Disease(CESD), Congenital, Hereditary, and Neonatal Diseases and Abnormalities, +12 more
Locations
  • Stanford, California, United States
  • New York, United States
  • Pittsburgh, Pennsylvania, United States
  • Prague, Czechia
View Trial Details
Completed

Extension Study to Evaluate the Long-Term Safety, Tolerability, and Efficacy of SBC-102 (Sebelipase Alfa) in Adult Subjects With Lysosomal Acid Lipase Deficiency

NCT01488097

Conditions
Cholesterol Ester Storage Disease, Cholesterol Ester Storage Disease (CESD), Congenital, Hereditary, and Neonatal Diseases and Abnormalities, +12 more
Locations
  • Eureka, California, United States
  • Sacramento, California, United States
  • San Francisco, California, United States
  • Minneapolis, Minnesota, United States
View Trial Details

Related conditions